Structural Heart > TAVI Portfolio > ACURATE neo2 Aortic Valve System > TAVI Valve Technology

The Technology


Our newest valve builds upon the ACURATE platform while introducing key innovations thoughtfully designed to help you optimize TAVI, from access to outcomes.

Improved PVL with Next-Generation Sealing Technology*1

The new Active PVseal Technology™ was designed to conform to the native aortic annulus and actively seal to minimize potential PVL †,1

Get the Data
ACURATE neo2™ PVL
Text

Active PVseal™ Technology

Designed to minimize PVL and potentially help treat more calcified annuli*1

Text
  View Video  

*Compared to ACURATE neo
1. Transcatheter Aortic Valve Replacement With the ACURATE neo2 Valve System: 1 Year Clinical and Hemodynamic Outcomes. Presented by H. Möllmann at TVT Chicago 2019.
†Limited clinical data has shown a numerical decrease in frequency and severity of PVL in ACURATE neo2 as compared to ACURATE neo.

 

 

Access Small & Complex Vessel Anatomies Pair with 14F iSLEEVE

Easy and Accurate Positioning

Keep positioning in sight with the new Radiopaque Positioning Marker - designed to provide clear visual reference so you can confidently position the valve within the annulus for a faster and more efficient procedure.*,1,2 †

Easy and Accurate Positioning
  View Video  

*Compared to ACURATE neo
† Average device usage time ± 3.5 min.
1. Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes. Presented by H. Mollmann at PCR London Valves 2018.
2. Möllmann H, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI-TF registry. EuroIntervention. 2018;13:e1764-e1770.

 

 

A Heart Team Decision

The ACURATE neo2 Aortic Valve System is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be appropriate for the transcatheter heart valve replacement therapy.*

 

*See DFU for details

 

Stable and Predictable by Design

Top Down Deployment delivers the hemodynamic stability and positioning accuracy needed for high procedural success and low complication rates1.2

See the data>

 

*See DFU for details
1. Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes. Presented by H. Mollmann at PCR London Valves 2018.
2. Möllmann H, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI-TF registry. EuroIntervention. 2018;13:e1764-e1770

 

 

Access Small & Complex Vessel Anatomies Pair with 14F iSLEEVE

Access Small & Complex Vessel Anatomies with 14F iSLEEVE

The 14F iSLEEVE™ Expandable Introducer simplifies access with its low profile providing a smooth insertion. The responsive Tri-Fold design provides SMART Expansion to address small and complex vasculatures (≥ 5.5mm).

Access Small & Complex Vessel Anatomies Pair with 14F iSLEEVE
  View Video  
 
 
 

 

 

Sign Up

Get exclusive product updates, training and educational opportunities, and more.
  Join Now  
 
Top